ORGANOIDS AND SPHEROIDS MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2023-12-20 |   Pages: 200+ |   Report ID: MD-R-2023-12-20-198908 |   Healthcare

Historical data: 2018 - 2023

Forecast period: 2024 - 2031

Quantitative units: Revenue in USD million and CAGR from 2024 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Organoids And Spheroids Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL ORGANOIDS AND SPHEROIDS MARKET

7.1 GLOBAL ORGANOIDS AND SPHEROIDS MARKET SIZE AND SHARE (2018-2031) (USD MILLION)

8.1 GLOBAL ORGANOIDS AND SPHEROIDS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

8.2 GLOBAL ORGANOIDS AND SPHEROIDS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

9.1 GLOBAL ORGANOIDS AND SPHEROIDS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

9.2 GLOBAL ORGANOIDS AND SPHEROIDS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

10.1 GLOBAL ORGANOIDS AND SPHEROIDS MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)

10.2 GLOBAL ORGANOIDS AND SPHEROIDS MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)

11.1 NORTH AMERICA ORGANOIDS AND SPHEROIDS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

11.2 NORTH AMERICA ORGANOIDS AND SPHEROIDS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

11.3 NORTH AMERICA ORGANOIDS AND SPHEROIDS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

11.4 NORTH AMERICA ORGANOIDS AND SPHEROIDS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

11.5 NORTH AMERICA ORGANOIDS AND SPHEROIDS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

11.6 NORTH AMERICA ORGANOIDS AND SPHEROIDS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

12.1 EUROPE ORGANOIDS AND SPHEROIDS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

12.2 EUROPE ORGANOIDS AND SPHEROIDS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

12.3 EUROPE ORGANOIDS AND SPHEROIDS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

12.4 EUROPE ORGANOIDS AND SPHEROIDS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

12.5 EUROPE ORGANOIDS AND SPHEROIDS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

12.6 EUROPE ORGANOIDS AND SPHEROIDS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

13.1 ASIA PACIFIC ORGANOIDS AND SPHEROIDS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

13.2 ASIA PACIFIC ORGANOIDS AND SPHEROIDS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

13.3 ASIA PACIFIC ORGANOIDS AND SPHEROIDS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

13.4 ASIA PACIFIC ORGANOIDS AND SPHEROIDS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

13.5 ASIA PACIFIC ORGANOIDS AND SPHEROIDS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

13.6 ASIA PACIFIC ORGANOIDS AND SPHEROIDS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

14.1 LATIN AMERICA ORGANOIDS AND SPHEROIDS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>

14.2 LATIN AMERICA ORGANOIDS AND SPHEROIDS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

14.3 LATIN AMERICA ORGANOIDS AND SPHEROIDS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

14.4 LATIN AMERICA ORGANOIDS AND SPHEROIDS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

14.5 LATIN AMERICA ORGANOIDS AND SPHEROIDS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

14.6 LATIN AMERICA ORGANOIDS AND SPHEROIDS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA ORGANOIDS AND SPHEROIDS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA ORGANOIDS AND SPHEROIDS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA ORGANOIDS AND SPHEROIDS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA ORGANOIDS AND SPHEROIDS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA ORGANOIDS AND SPHEROIDS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA ORGANOIDS AND SPHEROIDS MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>

16.1 3D Biomatrix

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 3D Biotek LLC

16.3 AMS Biotechnology (Europe) Limited

16.4 ATCC

16.5 Cellesce Ltd.

16.6 Corning Incorporated

16.7 Greiner Bio-One

16.8 Hubrecht Organoid Technology (HUB)

16.9 InSphero/Perkin Elmer

16.10 Kuraray

16.11 Lonza

16.12 Merck KGaA

16.13 Prellis Biologics

16.14 STEMCELL Technologies Inc.

16.15 Thermo Fisher Scientific, Inc.

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

By Type
Organoids
 o By Type
   o Neural Organoids
   o Hepatic Organoids
   o Intestinal Organoids
   o Other Organoids
 o By Method
   o General Submerged Method for Organoid Culture
   o Crypt Organoid Culture Techniques
   o Air Liquid Interface (ALI) Method for Organoid Culture
   o Clonal Organoids from Lgr5+ Cells
   o Brain and Retina Organoid Formation Protocol
 o By Source
   o Primary Tissues
   o Stem Cells
Spheroids
 o By Type
   o Multicellular tumor spheroids (MCTS)
   o Neurospheres
   o Mammospheres
   o Hepatospheres
   o Embryoid bodies
 o By Method
   o Micropatterned Plates
   o Low Cell Attachment Plates
   o Hanging Drop Method
   o Others
 o By Source
   o Cell Line
   o Primary Cell
   o iPSCs Derived Cells
 

By Aplication  
Developmental Biology
Personalized Medicine
Regenerative Medicine
Disease Pathology Studies
Drug Toxicity & Efficacy Testing

By End-use
Biotechnology and pharmaceutical industries
Academic & Research Institutes
Hospitals and diagnostic centers

Companies

3D Biomatrix
3D Biotek LLC
AMS Biotechnology (Europe) Limited
ATCC
Cellesce Ltd.
Corning Incorporated
Greiner Bio-One
Hubrecht Organoid Technology (HUB)
InSphero/Perkin Elmer
Kuraray
Lonza
Merck KGaA
Prellis Biologics
STEMCELL Technologies Inc.
Thermo Fisher Scientific, Inc.

Single User License  : 3900$
Corporate License    : 7800$
Enquiry Before Buying
Request For Customization
Speak To Analyst

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE

    • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY

    • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH

    • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING

    • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.